Event details

Date

Time

Duration

May 14th 2020

EET: 17:00-18:00
CET: 16:00-17:00
GMT: 15:00-16:00

60mins

Register Now

This webinar is organised and funded by Lundbeck

 Brintellix logo RGB

Vortioxetine is indicated for the treatment of major depressive episodes in adults.

 

Lundbeck’s products will be discussed during this webinar.
Prescribing information and adverse event reporting will be available at the main event page.

 

The webinar will discuss the prevalence of emotional blunting in patients with Major Depressive Disorder (MDD), its impact on patients’ lives and the neurophysiological explanation for emotional blunting. Real-world observations from clinical practice will be discussed via a series of case studies exploring approaches to identifying and addressing the issue in clinical practice.

Presenter

McIntyre_Roger

Professor Roger McIntyre

Professor of Psychiatry and Pharmacology, University of Toronto

View Bio

Professor McIntyre is currently Professor of Psychiatry and Pharmacology at the University of Toronto, and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto, Canada. After completing his medical degree at Dalhousie University, Professor McIntyre received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto in Canada.

Professor McIntyre is involved in multiple research endeavours which primarily aim to characterise the association between mood disorders and medical comorbidity. This research involves elucidating metabolic adverse events associated with the use of psychotropic medications, the impact of medical comorbidity on the course of mood disorders, and the effect of glucose homeostasis on neurocognition. Professor McIntyre was named by Thomson Reuters in 2014, as one of The World’s Most Influential Scientific Minds. This distinction was bestowed upon researchers who publish the largest number of articles that rank among those most frequently cited in 21 broad fields of science during the previous decade.

With extensive involvement in medical education, Professor McIntyre is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry, and has been a recipient of the joint Canadian Psychiatric Association (CPA)/Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada. Professor McIntyre is the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Professor McIntyre has published extensively in leading peer-reviewed journals and textbooks. He is also a reviewer for many journals, including the American Journal of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, and The New England Journal of Medicine.

Register

For additional information please visit our Privacy Notice.

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.